PRKN and Parkinson disease: Since USP14 inhibition promotes PINK1/Parkin-mediated mitophagy [26], and USP14 modulates the degradation of tyrosine hydroxylase [27], the rate-limiting enzyme in dopamine biosynthesis, we hypothesize that USP14 may be related to PD.